Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-17

Clinical Trial Update: Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating sublingual and transdermal nitroglycerin to improve image quality in coronary CT angiography has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NITROGLYCERIN (Nitroglycerin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-09-17